Is MLPH or ORCC a better dividend investment in 2026?

MLPH currently yields 250000.00% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: MLPH offers higher current income.

What is the dividend yield difference between MLPH and ORCC?

MLPH has a forward dividend yield of 250000.00% ($2.00/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 249990.21 percentage points.

Home › Compare › MLPH vs ORCC

MLPH vs ORCC: Dividend Comparison 2026

MLPH yields 250000.00% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MLPH wins by $4.567699004441311e+30M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MLPH

● Live price

250000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.567699004441311e+30M

Annual income

$4,564,107,688,187,857,300,000,000,000,000,000,000.00

Full MLPH calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — MLPH vs ORCC

📍 MLPH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MLPH	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MLPH + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MLPH pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MLPH

Annual income on $10K today (after 15% tax)

$21,250,000.00/yr

After 10yr DRIP, annual income (after tax)

$3,879,491,534,959,678,500,000,000,000,000,000,000.00/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, MLPH beats the other by $3,879,491,534,959,678,500,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MLPH + ORCC for your $10,000?

MLPH: 50%ORCC: 50%

100% ORCC50/50100% MLPH

Portfolio after 10yr

$2.2838495022206556e+30M

Annual income

$2,282,053,844,093,928,700,000,000,000,000,000,000.00/yr

Blended yield

99.92%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

MLPH

No analyst data

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MLPH buys

ORCC buys

No recent congressional trades found for MLPH or ORCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMLPHORCC

Forward yield	250000.00% ✓	9.79%
Annual dividend / share	$2.00 ✓	$1.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0% ✓	-50%
Portfolio after 10y	$4.567699004441311e+30M	$21.4K ✓
Annual income after 10y	$4,564,107,688,187,857,300,000,000,000,000,000,000.00 ✓	$1.04
Total dividends collected	$4.567463897060879e+30M ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: MLPH vs ORCC ($10,000, DRIP)

Year	MLPH Portfolio	MLPH Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$25,010,700	$25,000,000.00	$11,190	$489.61	+$25.00M → MLPH
2	$58,462,976,402	$58,436,214,953.27	$12,229	$256.01	+$58462.96M → MLPH
3	$127,722,124,784,416	$127,659,569,399,665.92	$13,216	$130.74	+$127722124.77M → MLPH
4	$260,784,910,907,288,130	$260,648,248,233,768,800.00	$14,207	$66.02	+$260784910907.27M → MLPH
5	$497,657,939,618,196,950,000	$497,378,899,763,526,240,000.00	$15,234	$33.17	+$497657939618196.94M → MLPH
6	$887,590,576,640,622,200,000,000	$887,058,082,645,230,600,000,000.00	$16,317	$16.62	+$887590576640622208.00M → MLPH
7	$1,479,547,418,610,237,200,000,000,000	$1,478,597,696,693,231,600,000,000,000.00	$17,468	$8.32	+$1.4795474186102372e+21M → MLPH
8	$2,305,052,548,351,757,200,000,000,000,000	$2,303,469,432,613,844,500,000,000,000,000.00	$18,695	$4.16	+$2.3050525483517572e+24M → MLPH
9	$3,356,370,330,330,650,300,000,000,000,000,000	$3,353,903,924,103,914,000,000,000,000,000,000.00	$20,006	$2.08	+$3.3563703303306504e+27M → MLPH
10	$4,567,699,004,441,311,000,000,000,000,000,000,000	$4,564,107,688,187,857,300,000,000,000,000,000,000.00	$21,407	$1.04	+$4.567699004441311e+30M → MLPH

MLPH vs ORCC: Complete Analysis 2026

MLPH — Stock

Molecular Pharmacology (USA) Limited, a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States. The company, through its subsidiary, Molecular Pharmacology Pty. Ltd., develops analgesic and anti-inflammatory molecule, known as Tripeptofen for the treatment of common every-day pain. Its products are available in various dosage forms, formulations, line extensions, and package configurations. The company focuses on marketing its products through pharmaceutical distributors, and through collaborative dealings with companies in the United States and Europe. It also has an agreement with Dermatology Development Corporation to develop and market a range of therapeutic, cosmetic, and cosmecutical products based on the ThermaLIFE product range and its active ingredient. The company is based in Perth, Australia. Molecular Pharmacology (USA) Limited is a subsidiary of PharmaNet Group Limited.

Full MLPH Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this MLPH vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MLPH vs SCHD MLPH vs JEPI MLPH vs O MLPH vs KO MLPH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.